SCHEDULE: Blue Owl Capital Reports 4.84% Stake in ImageneBio
Beneficial Ownership Report
Blue Owl Capital Holdings LP has reported a 4.84% passive beneficial ownership stake in ImageneBio, Inc. as of September 30, 2025.
Summary
- Blue Owl Capital Holdings LP reported beneficial ownership of 540,924 shares of ImageneBio, Inc. common stock.
- This stake represents 4.84% of ImageneBio's total outstanding common stock.
- The percentage is calculated based on 11,181,676 shares of common stock outstanding as of July 25, 2025.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating a passive investment.
- The securities were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing the control of ImageneBio, Inc.
Sentiment
Score: 6
Explanation: The filing reports a significant passive ownership stake by an institutional investor, which can be viewed as a positive signal of confidence in the issuer, ImageneBio, Inc., although the filing itself is purely factual.
Positives
- A notable institutional investor, Blue Owl Capital Holdings LP, holds a significant passive stake in ImageneBio, Inc., which can be interpreted as a signal of confidence in the company.
Future Outlook
This Schedule 13G filing does not contain any forward-looking statements or guidance from ImageneBio, Inc. or the reporting person regarding future operations or financial performance.
Industry Context
This filing indicates continued institutional investor interest in companies like ImageneBio, Inc., which is common in sectors such as biotechnology or pharmaceuticals, where early-stage companies often attract passive investment from funds.
Stakeholder Impact
- Shareholders: Existing shareholders may perceive the institutional investment as a positive indicator of confidence in ImageneBio, Inc., potentially influencing market sentiment.
Key Dates
| Date | Description |
|---|---|
| July 25, 2025 | Date as of which 11,181,676 shares of Common Stock were outstanding, as reported in the Issuer's Form S-1. |
| September 8, 2025 | Date of ImageneBio, Inc.'s registration statement on Form S-1 filed with the SEC. |
| September 30, 2025 | Date of the event which required the filing of this statement (beneficial ownership threshold). |
| November 14, 2025 | Date the Schedule 13G was signed by Blue Owl Capital Holdings LP. |
Keywords
ImageneBio, Blue Owl Capital, Schedule 13G, beneficial ownership, common stock, institutional investment, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.